Results 181 to 190 of about 314,849 (336)
This narrative review summarizes evidence for effective patient education on parenteral anticancer therapies. The authors propose a structured framework for oncology pharmacist‐led patient education on parenteral anticancer therapies that combines pharmacotherapy knowledge and the application of patient‐centered care.
Erin Hickey Zacholski +7 more
wiley +1 more source
Splenectomy for thrombocytopenia in chronic granulocytic leukemia [PDF]
George P. Canellos +2 more
openalex +1 more source
This study was to evaluate the relationship between Controlled Nutritional Status(CONUT) score and prolonged ICU stay in patients with pneumonia complicated by respiratory failure who underwent invasive mechanical ventilation. CONUT severe grade, history of smoking, hypertension, and blood transfusion were independently associated with prolonged ICU ...
Zhijuan Zheng, Guixia Peng, Yue Xiao
wiley +1 more source
Abstract Idecabtagene vicleucel (ide‐cel, ABECMA) is an autologous, B‐cell maturation antigen‐directed, chimeric antigen receptor (CAR) T‐cell therapy, which has demonstrated significantly improved progression‐free survival (PFS) and overall response rate (ORR) in patients with triple‐class‐exposed relapsed/refractory multiple myeloma (TCE RRMM). Here,
Fan Wu +11 more
wiley +1 more source
Characteristics and risk factors for thrombocytopenia in malignancy patients with pulmonary embolism: a case control study. [PDF]
Kong H +9 more
europepmc +1 more source
Immune thrombocytopenia in lymphoproliferative diseases [PDF]
BR Kaden, WF Rosse, TW Hauch
openalex +1 more source
Abstract Valemetostat is a dual inhibitor of EZH2/1 approved in Japan for the treatment of relapsed/refractory (R/R) adult T–cell lymphoma/leukemia (ATLL) and R/R peripheral T–cell lymphoma (PTCL). It is administered orally once daily (QD) at 200 mg. Here, we present comprehensive population pharmacokinetic (PPK) and exposure–response (ER) analyses of ...
Hiroyuki Inoue +7 more
wiley +1 more source
Risk factors of thrombocytopenia in adults receiving extracorporeal membrane oxygenation support: A single center retrospective cohort study. [PDF]
Tong H +6 more
europepmc +1 more source
Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients [PDF]
Banas, B. +3 more
core +1 more source

